World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 94 10355 9720 5325 4919 506 39010

Glenn J. Jaffe publications per year

The chart shows the history of publications by Glenn J. Jaffe between 1986 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Glenn J. Jaffe published across 40 years, from 1986 to 2025, averaging 13.5 papers a year. Output peaked at 35 publications in 2017. 27 of the 540 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 1986 to 2025. Vertical axis: number of publications, 0 to 35. Peak 35 publications in 2017. 1986: 2 publications 1987: 2 publications 1988: 7 publications 1989: 7 publications 1990: 8 publications 1991: 5 publications 1992: 9 publications 1993: 9 publications 1994: 9 publications 1995: 8 publications 1996: 15 publications 1997: 9 publications 1998: 4 publications 1999: 8 publications 2000: 13 publications 2001: 4 publications 2002: 10 publications 2003: 9 publications 2004: 8 publications 2005: 11 publications 2006: 21 publications 2007: 10 publications 2008: 10 publications 2009: 9 publications 2010: 6 publications 2011: 12 publications 2012: 20 publications 2013: 24 publications 2014: 17 publications 2015: 26 publications 2016: 30 publications 2017: 35 publications 2018: 22 publications 2019: 20 publications 2020: 30 publications 2021: 35 publications 2022: 12 publications 2023: 17 publications 2024: 10 publications 2025: 17 publications
1986 2025

540 publications in total across all disciplines

View publications per year as a table
Glenn J. Jaffe: publications per year, 1986 to 2025
Year Publications
1986 2
1987 2
1988 7
1989 7
1990 8
1991 5
1992 9
1993 9
1994 9
1995 8
1996 15
1997 9
1998 4
1999 8
2000 13
2001 4
2002 10
2003 9
2004 8
2005 11
2006 21
2007 10
2008 10
2009 9
2010 6
2011 12
2012 20
2013 24
2014 17
2015 26
2016 30
2017 35
2018 22
2019 20
2020 30
2021 35
2022 12
2023 17
2024 10
2025 17
Total 540
Download as CSV

Glenn J. Jaffe publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Glenn J. Jaffe sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 501–520 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 506 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617 506
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Glenn J. Jaffe D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Glenn J. Jaffe sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 94–95 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 94 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808 94
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Glenn J. Jaffe is affiliated with Duke University in the United States and has a research focus primarily within the field of Medicine, with a specific emphasis on Ophthalmology. Their scholarly work extensively addresses retinal diseases and treatments, retinal imaging and analysis, and conditions affecting the retina and optic nerves. Other areas of interest include ocular diseases such as Behçet's syndrome, glaucoma and related retinal disorders, retinal development, and macular surgery.

Jaffe's publication record demonstrates a consistent contribution to notable ophthalmology-related journals. Among the frequent venues are:

  • Ophthalmology
  • Ophthalmology Retina
  • Ophthalmology Science
  • American Journal of Ophthalmology
  • Retina

Their recent papers cover specialized topics in retinal research and therapies. Notable recent publications include:

  • C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration (2020, Ophthalmology)
  • HAWK and HARRIER (2020, Ophthalmology)
  • Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab (2020, Ophthalmology)
  • Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial (2023, The Lancet)
  • Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration (2020, Ophthalmology)

Collaboration appears to be a key aspect of Jaffe's work, with frequent coauthors including Maureen G. Maguire, Frank G. Holz, Arshad M. Khanani, Charles C. Wykoff, and Daniel Martín. These collaborators have contributed to multiple publications, indicating ongoing research partnerships in related subfields.

Jaffe's research spans several subfields within Medicine, particularly:

  • Ophthalmology
  • Radiology, Nuclear Medicine and Imaging
  • Molecular Biology
  • Neurology
  • Epidemiology

The main topics covered in their work further detail their research scope:

  • Retinal Diseases and Treatments
  • Retinal Imaging and Analysis
  • Retinal and Optic Conditions
  • Ocular Diseases and Behçet's Syndrome
  • Glaucoma and retinal disorders
  • Retinal Development and Disorders
  • Retinal and Macular Surgery

Overall, Glenn J. Jaffe's scholarly contributions center on advancing understanding and treatments related to retinal health, leveraging both clinical trials and imaging technologies to address various ocular conditions within the broader framework of ophthalmology.

Best Publications

  • Ranibizumab and bevacizumab for neovascular age-related macular degeneration.

    Daniel F Martin;Maureen G Maguire;Gui-shuang Ying

  • Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.

    Daniel F. Martin;Maureen G. Maguire;Stuart L. Fine;Gui Shuang Ying

  • Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel

    Douglas A. Jabs;James T. Rosenbaum;C.Stephen Foster;Gary N. Holland

  • Intravitreal aflibercept for diabetic macular edema.

    Jean François Korobelnik;Diana V. Do;Ursula Schmidt-Erfurth;David S. Boyer

  • Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration: Ninety-Six–Week Results of the VIEW Studies

    Ursula Schmidt-Erfurth;Peter K. Kaiser;Jean François Korobelnik;David M. Brown

  • Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials

    Maureen G. Maguire;Daniel F. Martin;Gui shuang Ying;Glenn J. Jaffe

  • Optical coherence tomography to detect and manage retinal disease and glaucoma.

    Glenn J. Jaffe;Joseph Caprioli

  • Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3.

    Srinivas R. Sadda;Robyn Guymer;Frank G. Holz;Steffen Schmitz-Valckenberg

  • Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.

    David M. Brown;Ursula Schmidt-Erfurth;Diana V. Do;Frank G. Holz

  • Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.

    Glenn J. Jaffe;Daniel Martin;David Callanan;P. Andrew Pearson

  • Adalimumab in Patients with Active Noninfectious Uveitis

    Glenn J Jaffe;Andrew David Dick;Andrew David Dick;Antoine P Brézin;Quan Dong Nguyen

  • Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials.

    Juan E. Grunwald;Ebenezer Daniel;Jiayan Huang;Gui Shuang Ying

  • Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial

    Quan Dong Nguyen;Pauline T. Merrill;Glenn J. Jaffe;Andrew D. Dick;Andrew D. Dick

  • cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium.

    S Haskill;G Martin;L Van Le;J Morris

  • Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies

    Jeffrey S. Heier;Jean François Korobelnik;David M. Brown;Ursula Schmidt-Erfurth

  • Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results.

    D G Callanan;G J Jaffe;D F Martin;P A Pearson

  • Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration

    Kang Zhang;Jill J. Hopkins;Jeffrey S. Heier;David G. Birch

  • Baseline Predictors for One-Year Visual Outcomes with Ranibizumab or Bevacizumab for Neovascular Age-related Macular Degeneration

    Gui Shuang Ying;Jiayan Huang;Maureen G. Maguire;Glenn J. Jaffe

Frequent Co-Authors

Cynthia A. Toth
Cynthia A. Toth Duke University
Maureen G. Maguire
Maureen G. Maguire University of Pennsylvania
Sina Farsiu
Sina Farsiu Duke University
Frank G. Holz
Frank G. Holz University of Bonn
Frederick L. Ferris
Frederick L. Ferris National Institutes of Health
Emily Y. Chew
Emily Y. Chew National Institutes of Health
Andrew D. Dick
Andrew D. Dick University of Bristol
Jennifer E. Thorne
Jennifer E. Thorne Johns Hopkins University
Srinivas R. Sadda
Srinivas R. Sadda University of California, Los Angeles
Ursula Schmidt-Erfurth
Ursula Schmidt-Erfurth Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a future in medicine doesn’t always mean pursuing a traditional MD in the USA. Many students explore flexible, affordable online programs that open doors to a variety of healthcare careers. For instance, aspiring nurse practitioners can save both time and money by enrolling in one of the cheapest dnp online programs available, earning a Doctor of Nursing Practice degree from home.

If pharmacy is more your focus, a number of accredited online pharmacist programs allow you to study for a PharmD while balancing work and family obligations. Beyond clinical roles, there are also opportunities in health administration and data management. Those interested in healthcare systems can check out him programs to build expertise in electronic medical records and compliance.

For students seeking a fast track into the healthcare field, online certification in medical coding and billing is a popular choice. The medical billing and coding certification cost is often lower than other healthcare educational paths, with short courses that qualify graduates for in-demand entry-level positions. These online options provide flexible and diverse pathways in the ever-growing US healthcare sector.

Best Scientists Citing Glenn J. Jaffe

Trending Scientists

Recently Published Articles